» Articles » PMID: 26887380

The Brain NO Levels and NOS Activities Ascended in the Early and Middle Stages and Descended in the Terminal Stage in Scrapie-Infected Animal Models

Overview
Journal Mol Neurobiol
Date 2016 Feb 19
PMID 26887380
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The infections of prion agents may cause progressive and fatal neurodegenerative diseases in humans and a serial of animal species. Previous studies have proposed that the levels of nitric oxide (NO) and nitric oxide synthase (NOS) in the brains of some neurodegeneration diseases changed, while S-nitrosylation (SNO) of many brain proteins altered in prion diseases. To elucidate the potential changes of brain NO levels during prion infection, the NO levels and NOS activities in the brain tissues of three scrapie experimental rodents were measured, including scrapie agent 263 K-infected hamsters and 139A- and ME7-infected mice. Both NO levels and NOS activities, including total NOS (TNOS) and inducible NOS (iNOS), were increased at the terminal stages of scrapie-infected animals. Assays of the brain samples collected at different time points during scrapie infection showed that the NO levels and NOS activities started to increase at early stage, reached to the peak in the middle stage, and dropped down at late stage. Western blots for brain iNOS revealed increased firstly and decreased late, especially in the brains of 139A- and ME7-infected mice. In line with those alterations, the levels of the SNO forms of several selected brain proteins such as aquaporin-1 (AQP1), calcium/calmodulin-dependent protein kinase II (CaMKII), neurogranin, and opalin, underwent similar changing trends, while their total protein levels did not change obviously during scrapie infection. Our data here for the first time illustrate the changing profile of brain NO and NOS during prion infection. Time-dependent alterations of brain NO level and the associated protein S-nitrosylation process may contribute greatly to the neuropathological damage in prion diseases.

Citing Articles

Extensive Disturbances of Intracellular Components and Dysfunctions of Biological Pathways in the Brain Tissues During Prion Infection - China's Studies.

Shi Q, Chen C, Xiao K, Zhou W, Gao C, Gao L China CDC Wkly. 2022; 4(33):741-747.

PMID: 36285114 PMC: 9547740. DOI: 10.46234/ccdcw2022.154.


Mapping Molecular Networks within Linn. against LPS-Induced Neuroinflammation in Microglial Cells, with Molecular Docking and In Vivo Toxicity Assessment in Zebrafish.

Mat Zian N, Swain P, Mohd Faudzi S, Zakaria N, Ibrahim W, Abu Bakar N Pharmaceuticals (Basel). 2022; 15(4).

PMID: 35455463 PMC: 9032563. DOI: 10.3390/ph15040467.


The effects of S-nitrosylation-induced PPARγ/SFRP5 pathway inhibition on the conversion of non-alcoholic fatty liver to non-alcoholic steatohepatitis.

Wang H, Li F, Feng J, Wang J, Liu X Ann Transl Med. 2021; 9(8):684.

PMID: 33987382 PMC: 8106108. DOI: 10.21037/atm-21-1070.


Inhibition of neuroinflammatory nitric oxide signaling suppresses glycation and prevents neuronal dysfunction in mouse prion disease.

Bourgognon J, Spiers J, Robinson S, Scheiblich H, Glynn P, Ortori C Proc Natl Acad Sci U S A. 2021; 118(10).

PMID: 33653950 PMC: 7958397. DOI: 10.1073/pnas.2009579118.


Prions Strongly Reduce NMDA Receptor S-Nitrosylation Levels at Pre-symptomatic and Terminal Stages of Prion Diseases.

Meneghetti E, Gasperini L, Virgilio T, Moda F, Tagliavini F, Benetti F Mol Neurobiol. 2019; 56(9):6035-6045.

PMID: 30710214 DOI: 10.1007/s12035-019-1505-6.


References
1.
Endoh M, Maiese K, Wagner J . Expression of the inducible form of nitric oxide synthase by reactive astrocytes after transient global ischemia. Brain Res. 1994; 651(1-2):92-100. DOI: 10.1016/0006-8993(94)90683-1. View

2.
Yew D, Wong H, Li W, Lai H, Yu W . Nitric oxide synthase neurons in different areas of normal aged and Alzheimer's brains. Neuroscience. 1999; 89(3):675-86. DOI: 10.1016/s0306-4522(98)00383-2. View

3.
Nakamura T, Tu S, Akhtar M, Sunico C, Okamoto S, Lipton S . Aberrant protein s-nitrosylation in neurodegenerative diseases. Neuron. 2013; 78(4):596-614. PMC: 3712898. DOI: 10.1016/j.neuron.2013.05.005. View

4.
Imran M, Mahmood S . An overview of human prion diseases. Virol J. 2011; 8:559. PMC: 3296552. DOI: 10.1186/1743-422X-8-559. View

5.
Santamaria D, Rios C, Santamaria A . Nomega-nitro-L-arginine, a nitric oxide synthase inhibitor, antagonizes quinolinic acid-induced neurotoxicity and oxidative stress in rat striatal slices. Neurochem Res. 1999; 24(7):843-8. DOI: 10.1023/a:1020949812581. View